Pillar Biosciences OncoReveal CDx Pan-cancer Solid Tumor IVD Now FDA Approved for General Tumor Profiling on the Illumina MiSeq Dx System

Company continues to execute on its global strategy to bring highly accurate and sensitive NGS cancer diagnostics to enable localized testingNATICK, Mass., April 23, 2024 /PRNewswire/ -- Pillar Biosc

PR NewswireApr 23 22:00

Illumina (NASDAQ:ILMN) Investors Are Sitting on a Loss of 71% If They Invested Three Years Ago

Yahoo FinanceApr 23 19:38

Top High Growth Investment Ratio Stocks From Each Sector - GS

Seeking AlphaApr 23 04:25

Illumina, Inc.'s (NASDAQ:ILMN) Share Price Not Quite Adding Up

Illumina, Inc.'s (NASDAQ:ILMN) price-to-sales (or "P/S") ratio of 4.2x may not look like an appealing investment opportunity when you consider close to half the companies in the Life Sciences industry

Simply Wall StApr 22 20:19

Engineering a Cool Career in Biotech - and Volunteering Along the Way

What kind of opportunities can an engineer find through their work? Plenty, at Illumina! One employee shares how she makes a difference.Originally published on Illumina News Center NORTHAMPTON, MA / A

AccesswireApr 19 01:30

Evidence Supports Sequencing As First-Line Rare Disease Diagnostic

The Medical Genome Initiative presents a paper in an effort to expand patient access to sequencingOriginally published on Illumina News CenterNORTHAMPTON, MA / ACCESSWIRE / April 17, 2024 / A recent l

AccesswireApr 17 21:30